Electron-capture gas-liquid chromatography was used for simultaneous quantitatlon of plasma diazepam (I) and its major metabolite, desmethyldiazepam (ii). Because concentrations of Ican greatlyexceed those of ii aftersingle doses of I,two benzodlazepine-analog internal standards were added to all samples, thereby allowing reliable quantitatlon of high concentrationsof Iand low concentrations of Ii. Afterextraction at neutralpH withbenzene (containing isoamyi alcohol), the organic extract is evaporated and the residue Is reconstituted in a small volume of solvent and chromatographed on a 3% OV-17 column. The sensitivity limits are 2 to3 ng of Por iiper milliliter of original sample, with a CV for Identical samples of <5%. The applicability of the method to single-dose pharmacokinetic studiesof Pin humans isillustrated.
Methods and Materials

Apparatus and Chromatographic Conditions
We used a Hewlett Packard Model 5750 gas chromatograph equipped with a 2-mCi Ni electron-capture detector, operated in thepulsedmode with a pulseinterval of 150 ms.The column is coiled glass, 182 cm in length by 4mm i.d.,packed with 3% OV-17 on 80/100 mesh Chromosorb WHP (Supelco, Inc., Bellefonte, Pa.). The carrier gas is ultrapure helium (Matheson Gas Products, Gloucester, Mass.), flow rate, 50 ml/min. The purge gas is 95/5 argon/methane (flow rate, 80 mi/min). Operating temperatures are: injection port, 300 oC; column, 280 #{176}C; detector, 320 #{176}C. At the beginning of each working day, the column is primed by injection either of two to three drug-free blank plasma extracts, or of 2 to 3 iil of a 1 g/liter solution of asolectin (Associated Concentrates, Woodside, NY) in benzene. The need for subsequent priming injections depends upon the age of the column, and is assessed by evaluation of the stability of peak-height ratios after repeated injection of the same sample.
Preparation and Analysis of Samples
Ten milligrams of DZ and DMDZ, and of the two internal standard benzodiazepine analogs (1), Ro7-9957 and Ro7-9749 (Figure 1 ),1 each are dissolved in 2 to 3 ml of absolute ethanol, then diluted to 100 ml with benzene. The stock solutions, stored in amber-colored bottles at 4 #{176}C, are stable for at least a year. Working standards, containing 0.25 to 1.0 mg/liter, are prepared as needed by appropriate dilution with benzene.
A constant amount (usually 100 gil) of a working internal standard mixture, containing Ro7-9957 (0.7 mg/liter) and Ro7-9749 (0.3 mg/liter), is added to a series of conical 40-ml centrifuge tubes equipped with Teflon-lined screw-top caps. The solutions are evaporated to dryness at 40 to 50#{176}C under mildly reduced pressure. One milliliter ofdrug-free control plasma isadded toeach of the calibration tubes and I ml of "unknown" plasma to each oftheothertubeswhich contain only the internal standards. The calibration standards are extracted and analyzed daily, together with each set of unknowns. When plasma diazepam concentrations exceeding 250 ,ig/liter are anticipated, plasma aliquots of less than 1 ml (e.g., 0.1 ml) can be analyzed in parallel with the 1-ml sample. The final volume of plasma should be adjusted to 1.0 ml by addition of drug-free control plasma.
Six milliliters of benzene (containing 15 ml of isoamyl alcohol per liter) is added to all tubes. The tubes are agitated gently in the upright position on a vortex-type mixer for 30 s, then centrifuged at room temperature for 10 mm at 400 X g. A portion of the organic layer (about 5 ml) is transferred to a conical 13-mi centrifuge tube, then evaporated at 40 #{176}C under mildly reduced pressure. The residue is redissolved in 100 to 200 tl of benzene ortoluene(containing 150 ml of isoamyl alcohol per liter), of which 1 to 6 ii is injected into the chromatograph.
Clinical Pharmacokinetic Study
A healthy 29-year-old woman volunteer participated after giving written informed consent. A single 5-mg dose of diazepam was infuseddirectly intoan antecubital veinduring 15 s. During the subsequent 98 h multiplevenous blood samples from the otherarm were collected intoheparinized tubes.Plasma was separated and frozenuntilassay. DZ and DMDZ concentrations inallsampleswere determined asdescribed above.
Plasma DZ concentrations were subjectedto iterative weighted nonlinear least-squares regression analysis, to determine pharmacokinetic characteristics of diazepam distribution, elimination, and clearance (13, 14) .
Results
Evaluation of the Method
Absolute retention times of DZ, DMDZ, and the two internal standards (Figure 2 ) depend upon the age of the column, but relative retention times are independent of column age.
A linear relation exists between concentrations of DZ or DMDZ in the calibration standards and the peak-height ratio of each of the compounds to its respective internal standard (Figure 3) . The sensitivity limits are about 2 to 3 ng of DZ or DMDZ per milliliter of original sample. Coefficients of vanation for identical DZ samples (n = 8 at each concentration) were: 2.8%at 25 ng/ml; 4.3%at 50 ng/ml; 2.1%at 100 ng/ml; and 3.1% at 200 ng/ml. For DMDZ, the variation of identical samples at 25 ng/mi (n = 8) was 1 where C represents the plasma DZ concentration (in ng/ml or gig/liter) at time t (in hours) after the dose (Figure 4 ). DZ disappearance was mirrored by appearance of its metabolite,
DMDZ.
Based on the coefficients and exponents determined from the fitted function, the size of the dose, and the body weight of the subject (49.1 kg), the following pharmacokinetic vanables were determined (13, 14) : 
Discussion
Electron-capture gas-liquid chromaotgraphy is established as a sensitive and specific approach to quantitation of diazepam and desmethyldiazepam in human blood or plasma (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . The selectivity of the electron-capture detector obviates the need for extensive sample clean-up; plasma samples from drug-free individuals are consistently free of contaminants appearing at the retention times of DZ and DMDZ or of the two internal standards. Chromatographic peaks corresponding to all four compounds are symmetric, allowing use of peak height rather than peak area to quantitate detector response (15) .
The double internal standardization approach greatly facilitates single-dose pharmacokinetic studies of diazepam in humans. Relatively high concentrations of the parent compound are quantitated by using one reference standard (Ro7-9957) of which relatively large amounts are added to the original sample.Low concentrations of DMDZ, generated by hepaticdemethylation ofDZ, are quantitated with use of the other reference standard (Ro7-9749), added in smaller amounts. When concentrations of the parent compound also are low, the "low" standard (Ro7-9749) can also be used for measuring DZ.
The applicability of the method to clinical phanmacokiiietic investigations is illustrated. Consistent with previous reports (16) , disappearance of diazepam from plasma following a single intravenous bolus injection appeared to have three exponential phases. This complex pattern is consistent with a three-compartment open pharmacokinetic model, and indicates that diazepam is distributed to different tissues at different rates. The total apparent volume of distribution was estimated at 1.89 liter/kg, indicating extensive overall tissue uptake. Following attainment of distribution equilibrium, elimination proceeded with a typically long half-life of 31.7 h (16, 17) . Total metabolic clearance of diazepam was 0.69 ml/min per kilogram body weight. Diazepam appears to be cleared largely by hepatic demethylation (18) , yielding the metabolic product DMDZ, the appearance of which in plasma mirrors the disappearance of the parent compound. Because both compounds have similar pharmacologic activity (18) , bothmust be considered in attempts to determine the clinical relevance of the pharmacokinetic profile of diazepam in humans.
Minor modifications of the described method can be used for simultaneous quantitation of DZ and DMDZ during multiple-dose therapy. Chronic dosing with DZ leads to accumulation of both DZ and DMDZ (16, 19, 20 
